Spanish for urology clinic nurses: the patient who stopped his alpha-blocker for BPH because his blood pressure was low and did not know that was why, the patient who has not told her urologist about her urinary incontinence because she believes it is a normal part of aging, and the patient who received a prostate cancer diagnosis and has not told his wife yet

Aurelio Torres was sixty-eight years old, a retired city bus driver from Fresno, and he had been on tamsulosin 0.4 mg once daily for fourteen months. The AUA symptom score that had brought him to the urology clinic had been twenty-four — severe category. He had been getting up two or three times at night, standing at the toilet for thirty to forty seconds before anything started, and often finishing in a thin dribble that left him feeling like he had not gone at all. Fourteen months on tamsulosin had changed all of that. His most recent symptom score was eleven. He was sleeping through most nights. His stream was what he remembered from twenty years earlier.

Six weeks before his follow-up visit, his daughter came to dinner on a Sunday. She was taking a medical assistant certification program and had brought home a blood pressure cuff. After dinner she took Aurelio’s pressure sitting at the kitchen table: 112 over 72. He stood up to refill her water glass. She took it again: 89 over 58. He felt the room tilt slightly behind his eyes — a brief lightness that passed in three or four seconds. She told him that was too low. She told him to mention it to his doctor.

He thought about which medication was the newest addition. The tamsulosin was what they had added for the prostate. The logic was clear to him. He stopped the tamsulosin that evening.

Over the following two weeks, his stream narrowed again. He was up at 2 AM and again at 5 AM. He stood at the toilet for forty seconds before anything came. He told himself it was a bad stretch. He did not connect the return of his symptoms to stopping the medication. When the nurse asked at the follow-up visit how his urinary symptoms had been, he said “bien” and meant it — he had not framed the return of his prior symptoms as something worth reporting.

Three outpatient urology clinic patterns that arrive without announcing themselves: Aurelio, whose BPH had been controlled on tamsulosin for fourteen months and who stopped it six weeks ago because a standing blood pressure of 89/58 looked dangerous to his daughter — not knowing that orthostatic hypotension is an expected and manageable consequence of alpha-1 receptor blockade, not a signal the medication is harming him; Rosa Elena Vásquez, sixty-one, a preschool teacher’s aide from Pomona, referred by her PCP for urinary incontinence evaluation with the chart note “stress incontinence, mild, intermittent, per patient,” who told the urology intake nurse “a veces, un poquito” and has been restricting fluids since 7 AM on workdays, memorizing a forty-two-step route from her classroom to the nearest restroom, leaving eight minutes early from every break to arrive before urgency becomes unmanageable, keeping spare clothing in her car, and avoiding her neighborhood walking group for eight months because the route does not pass a restroom — none of which appears in the PCP’s chart note or the urology intake form; and Ernesto Gutiérrez, seventy-two, a retired carpenter from San Jose, diagnosed six weeks ago with Gleason 3+4=7, Grade Group 2, clinical T2a localized prostate cancer, who arrives alone for a treatment decision visit, having told no one in his family, because the word cáncer in his household means the eleven-month trajectory of his wife’s father’s metastatic lung cancer, and who does not know how to explain that what he has is different.

The patient who stopped his alpha-blocker for BPH because his blood pressure was low and did not know that was why

The nurse reviewing Aurelio’s chart before the follow-up visit saw the tamsulosin listed as an active medication. She also saw that the last pharmacy fill had been seven weeks ago — one week before the prior supply would have run out. She noted the gap and went in prepared.

She measured his vital signs. Sitting blood pressure: 128 over 76. She asked him to stand for two minutes and measured again: 106 over 64. A mild postural drop — no symptoms, well within the range she regularly saw in patients on alpha-blockers. She wrote it down and formed a hypothesis.

She opened: “¿Ha habido algún cambio en cómo está tomando el tamsulosín — la pastilla para la próstata — desde la última vez que vino?”

Aurelio: “Ah, sí. La dejé hace como seis semanas. Mi hija me tomó la presión y estaba muy baja cuando me paré. Me dijo que era peligroso.”

“¿A qué llegó la presión cuando se paró?”

“Ochenta y nueve sobre cincuenta y ocho. Ella se preocupó. Me dijo que eso era demasiado bajo.”

The nurse did not correct him immediately. She wrote down the number. Then: “¿Cómo ha estado la orina desde que dejó el medicamento? ¿Algún cambio?”

“Bueno, me estoy levantando más de noche otra vez. Dos veces, a veces tres. Y el chorro está más delgado. Pensé que era una mala semana.”

She wrote: AUA symptom range returning toward pre-treatment baseline. She knew exactly what had happened, and she knew the patient had made the most rational decision available to him with the information he had. His daughter was right that 89/58 standing was low. She was right that he should report it. What neither of them had was the vocabulary to distinguish between a dangerous side effect and an expected, manageable one.

She explained the mechanism. Not the conclusion — the mechanism first:

“El tamsulosín relaja el músculo liso. En la próstata, ese músculo es el que se estaba apretando alrededor del tubo de la orina y dificultando el flujo de orina. Cuando se relaja, el flujo mejora — ese es el beneficio que usted sintió estos catorce meses. El mismo tipo de músculo existe en las paredes de los vasos sanguíneos. Cuando el medicamento lo relaja ahí también, la presión puede bajar un poco cuando usted se levanta rápido — la sangre tarda un segundo más en subir al cerebro porque las paredes del vaso están más relajadas. Eso es lo que sintió cuando se paró esa tarde: el cuarto se movió un poco, duró unos segundos, se le pasó.”

Aurelio: “Sí, exactamente así.”

“Eso se llama hipotensión ortostática — baja de presión al cambiar de posición. Es un efecto conocido de este tipo de medicamento. No es una señal de que algo está fallando en su cuerpo — es la misma acción que le estaba ayudando la próstata, actuando en otro lugar al mismo tiempo. La lectura que le tomó su hija — ochenta y nueve sobre cincuenta y ocho de pie — es lo que vemos cuando el medicamento está en su punto máximo durante el día y usted cambia de posición. No es peligroso. Es predecible. Y hay tres cambios que lo eliminan completamente para la mayoría de los pacientes.”

She described all three. Take tamsulosin at bedtime instead of in the morning — the peak of alpha-blockade occurs while he is lying down and not changing position. Rise from bed slowly — sit at the edge of the bed for thirty seconds before standing, giving the blood vessels time to adjust. Stay hydrated through the day, because dehydration amplifies the postural blood pressure drop.

“Si lo toma a la hora de acostarse, el punto más alto del efecto ocurre mientras usted está acostado — no manejando, no bajándose de un carro, no cambiándose de posición. La bajada de presión pasa mientras usted duerme. A las dos o tres semanas de tomarlo por la noche, la mayoría de los pacientes no sienten nada al pararse por la mañana. Su hija puede medirle la presión de nuevo en ese punto. El número va a ser diferente.”

Aurelio restarted tamsulosin that night at bedtime. At his six-week follow-up call, his daughter had remeasured: 108 over 70 sitting, 98 over 64 standing. No dizziness. His nocturia was down to once. His stream was back.

At his next in-person visit, Aurelio arrived with his daughter. She said to the nurse: “Yo no sabía que se podía manejar. Pensé que había que cambiar el medicamento.”

Aurelio: “Nadie me había explicado que le pegaba a los vasos también. Si lo hubiera sabido, no lo habría dejado.”

She had been right to check. She had been right that he should report it. What the prescription had not come with — and what the pharmacy printout had listed under “side effects” without explaining what it meant or what to do about it — was the distinction between a side effect that requires stopping the medication and a side effect that requires changing when it is taken. That distinction is the nurse’s job to provide, ideally at the first prescription, so that the next blood pressure reading in the kitchen on a Sunday does not cost fourteen months of symptom control.

The patient who has not told her urologist about her urinary incontinence because she believes it is a normal part of aging

Rosa Elena Vásquez was sixty-one years old, a preschool teacher’s aide at a Head Start center in Pomona, and she had been referred by her PCP to the urology clinic for evaluation of urinary incontinence. The PCP’s referral note read: “stress incontinence, mild, intermittent, per patient. Refer for evaluation and possible pelvic floor PT vs pharmacologic management.”

The urology clinic nurse doing the new-patient intake had fifteen minutes. She opened with the standard questions.

“¿Con qué frecuencia tiene accidentes?”

Rosa Elena: “A veces. No mucho.”

“¿Cuántas veces va al baño durante el día?”

“Bastantes. Como ocho, o más. No sé exactamente.”

“¿Siente urgencia — que tiene que ir inmediatamente y no puede esperar?”

“A veces, sí.”

“¿Le gotea cuando tose, estornuda, o hace algo de esfuerzo?”

“Sí, un poquito a veces.”

Every answer was “a veces” and “un poquito.” Eight or more voids per day, urgency episodes, both stress and urge provocation — on a standard ICIQ-SF checklist this pattern would score moderate-to-severe. But Rosa Elena was not describing moderate-to-severe. She was describing something ordinary, unremarkable, barely worth mentioning. She had come to this appointment because her PCP told her to.

The nurse put down the checklist and shifted.

“¿Hay algo que haya tenido que cambiar en su rutina del día — en el trabajo, en las salidas, en lo que come o bebe — por este problema?”

Rosa Elena was quiet. Then: “Bueno. Tomo menos agua cuando trabajo.”

“¿Cuánta menos?”

“Casi nada desde las siete de la mañana. Hasta que llego a casa.”

The nurse wrote it down without changing her expression. “¿Por qué a las siete?”

“Porque entro a trabajar a las ocho. Quiero estar segura de que no voy a tener ningún problema antes del primer descanso.”

“¿Y si siente la urgencia antes del descanso?”

“Sé a dónde ir. Ya conozco el camino.”

There was a pause. Then Rosa Elena added: “Son cuarenta y dos pasos desde mi salón al baño más cercano. Y salgo ocho minutos antes del descanso para llegar antes de que me entre la urgencia.”

She had memorized the route. She had timed the walk. She left eight minutes early from every break so she could arrive at the restroom before the urgency became unmanageable. She had done this every workday for eight months.

The nurse: “¿Hay algo que haya dejado de hacer — salidas, actividades, reuniones con amigas — porque no quería tener que preocuparse de esto?”

Rosa Elena looked at the window for a moment. Then: “Dejé de salir a caminar con mis amigas. Les dije que me dolían los pies — que era otra cosa. Pero es que la ruta que hacemos no pasa cerca de ningún baño. Y no sé cuándo me va a entrar.”

She had stopped her walking group eight months ago. She kept a spare pair of underwear and pants in a canvas bag in her car. She had never mentioned the bag to anyone. She had been doing this for eight months.

The nurse completed the ICIQ-SF formally. Symptom frequency: daily. Amount: moderate. Impact on daily life, asked directly with a 0–10 scale now that the full picture existed: seven out of ten. Total score: 18/21. Severe range.

“Lo que usted está manejando no es ‘a veces un poquito.’ Lo que me está describiendo — no tomar líquidos desde las siete de la mañana, saber el camino exacto al baño, salir antes del descanso para llegar a tiempo, dejar de caminar con sus amigas, llevar ropa de repuesto en el carro — es un patrón severo. No por la frecuencia de los accidentes que tiene, sino por todo lo que ha cambiado en su vida para evitarlos. Eso es la información que el médico necesita. El tratamiento que corresponde a lo que me describió es diferente al que hubiera correspondido a ‘a veces un poquito.’”

Rosa Elena looked at her hands for a moment. “Pensé que era normal. Que así se pone el cuerpo después de los sesenta.”

“Es común — muchas mujeres lo experimentan. Pero no es algo que haya que aguantar. Es tratable. Y lo que usted tiene — esta combinación de urgencia y esfuerzo — responde bien al tratamiento en la mayoría de las pacientes. Hay dos caminos principales: terapia física del piso pélvico — ejercicios específicos con una fisioterapeuta especializada — y medicamento si la terapia sola no es suficiente. El médico va a hablar con usted de los dos.”

Before the physician visit, the nurse had the correct clinical picture: urgency-predominant mixed incontinence, ICIQ-SF 18/21, functional avoidance severe enough to restrict both fluid intake and social participation. The physician ordered a two-week bladder diary, referred Rosa Elena to a Spanish-speaking pelvic floor physical therapist, and discussed mirabegron as a pharmacologic option if PT alone was not sufficient.

At the follow-up after eight pelvic floor PT sessions, Rosa Elena walked in without the canvas bag in her car. She told the nurse she had gone back to her walking group. She had not told her friends why she had stopped. “Pero les dije que ya estaba mejor. Ya salimos los martes.”

The ICIQ-SF at the eight-week follow-up: 9/21. Moderate, trending. The bladder diary showed voids down to six per day. She had stopped restricting fluids after noon.

She had managed this alone for eight months because she had classified it as aging. The functional question reclassified it as something treatable in eleven words — and the classification change was what made the rest possible.

The patient who received a prostate cancer diagnosis and has not told his wife yet

Ernesto Gutiérrez was seventy-two years old, a retired carpenter from San Jose, and he had been diagnosed with prostate cancer six weeks before this visit.

The biopsy had returned Gleason 3+4=7, Grade Group 2, clinical T2a, PSA 6.8 ng/mL at diagnosis. The urologist had explained favorable intermediate-risk localized prostate cancer. He had presented three management options: active surveillance with quarterly PSA and annual biopsy, external beam radiation therapy, and radical prostatectomy. He had given Ernesto printed materials in English. He had scheduled this follow-up for questions and a treatment decision.

Ernesto arrived alone. He had been alone at the diagnosis visit too.

His wife, Graciela, believed he was going to “un chequeo de próstata rutinario.” His son in Salinas did not know about the biopsy. His daughter in San Jose did not know. No one in his family knew what the urologist had told him six weeks ago.

He had not told them because Graciela’s father had died of cancer. Lung cancer, metastatic, found on a chest X-ray taken as pre-operative clearance for a knee replacement. He had been dead in eleven months. Ernesto had watched the entire progression — the chemotherapy, the forty pounds he lost, the way Graciela had barely slept for three months at the end. He did not know how to say “encontraron cáncer” in a house where that word meant her father.

He also did not know how to explain the Gleason score, or what active surveillance meant, or whether waiting without treating was responsible or reckless. He did not know how to describe the three options in Spanish to someone who had never heard of any of them. So he had come back alone to make a decision about the rest of his life, without the person who had been there for forty-four years.

The nurse doing pre-visit intake saw the chart note from the diagnosis visit: “localized PCa Gleason 7 GG2 cT2a PSA 6.8, options reviewed, pt deferred, return for decision.” She reviewed the note. She went in prepared.

After vital signs and medication review, she said: “¿Ha tenido oportunidad de hablar con su esposa o sus hijos sobre lo que el médico le explicó en la última visita — el resultado de la biopsia y las opciones?”

Ernesto: “No. Todavía no.”

“¿Qué lo ha llevado a no compartirlo todavía?”

He looked at the wall. A long pause. Then: “Mi suegro murió de cáncer. Si le digo a mi esposa que tengo cáncer, va a pensar que me voy a morir igual que él. Y todavía no sé cómo explicarle que no es lo mismo.”

The nurse did not immediately say “esto no es lo mismo.” She named what he was carrying first.

“Lo que está cargando solo es mucho. Tomar una decisión médica importante y no tener con quién hablarla — y además estar buscando las palabras para que no suene a lo que usted ya vio de cerca — eso pesa. Lo que me acaba de pedir de forma indirecta — cómo explicarle que no es lo mismo — eso sí lo puedo ayudar con eso ahora mismo, si quiere.”

He nodded.

She explained the distinction he needed. Not the Gleason grading system in detail — that was the urologist’s conversation. The one distinction that mattered to him: metastatic versus localized.

“El cáncer de pulmón que tuvo el papá de su esposa — el que encontraron cuando iba a operarse la rodilla — era metastásico. Eso significa que cuando lo encontraron, ya se había extendido a otras partes del cuerpo — a los ganglios, a otros órganos. El tratamiento del cáncer metastásico es muy difícil porque el cáncer ya está en muchos lugares al mismo tiempo. Ese es el tipo de cáncer que la palabra ‘cáncer’ significa en su casa.”

“Lo que encontraron en su biopsia es diferente en algo fundamental: está localizado. Significa que está dentro de la próstata. No se ha extendido a los ganglios, no está en los huesos, no está en ningún otro órgano. Ese es el punto de partida completamente diferente del caso de su suegro.”

“Por eso el médico le presentó tres opciones — vigilancia activa, radiación, y cirugía. Si fuera lo mismo que lo de su suegro, no habría tres opciones. Habría urgencia. La existencia de tres opciones es en sí misma información importante sobre la etapa en que está.”

Ernesto was quiet. Then: “Eso sí no me lo habían explicado así.”

The nurse did not push him to decide whether to tell his wife. She offered him the language:

“Lo que le propongo no es que llegue a casa esta noche y diga ‘tengo cáncer.’ Lo que le propongo es que llegue y le diga a Graciela: ‘Fui al urólogo. Encontraron algo en la biopsia de la próstata. El médico me explicó que no es lo mismo que lo del papá — está adentro de la próstata, no se extendió. Quiero que vengas conmigo la próxima vez para que el médico nos explique las opciones a los dos.’ Esa es una conversación diferente. No empieza con la palabra cáncer sola. Empieza con lo que lo distingue del cáncer que ella conoce.”

“Su esposa lleva cuarenta y cuatro años con usted. Va a enterarse de esta decisión de una manera u otra — ahora, o cuando usted ya la haya tomado solo. La diferencia es que si ella entra ahora, puede hacerle preguntas al médico junto con usted, puede ayudarle a pensar las opciones, puede estar presente en algo que es de los dos. No tiene que cargar esto solo si no quiere.”

She left it there. She wrote in the chart: “Patient has disclosed diagnosis to no family members. Primary barrier: word ‘cáncer’ carries specific meaning of father-in-law’s metastatic lung ca (died 11 months post-Dx). Patient given framework for differentiating localized from metastatic in patient language. Patient given specific sentence for initiating conversation with wife. Patient receptive; no pressure applied. Will assess at next visit whether partner can attend.”

Three weeks later, Ernesto returned. Graciela came with him. She carried a small notebook. She had three questions written down. The urologist answered each one. She asked about urinary incontinence risk after radical prostatectomy, because she had read about it on a Spanish-language health site. She asked about the frequency of PSA monitoring under active surveillance and what would trigger moving from surveillance to treatment. She asked what happened if the cancer progressed during surveillance and whether the same options would still be available.

Ernesto chose active surveillance. His first quarterly PSA at three months: 6.4 ng/mL. Stable.

At the three-month follow-up, the nurse asked how things had been since Graciela came in. Ernesto said: “Mejor. No era el cáncer del papá de ella. Nada más que hubiera querido que alguien me lo explicara así desde el principio. Estuve seis semanas cargando solo una cosa que no era lo que yo creía que era.”

Graciela’s three notebook questions, and the answers she received that afternoon, were what made active surveillance sustainable. Quarterly PSA checks and annual biopsies live in the household, not just in the clinic. A patient managing localized prostate cancer under active surveillance who has a partner who understands the monitoring logic — who knows what number would prompt concern and what would not — is a different patient from one managing it alone.

The three questions for every urology clinic visit with a Spanish-speaking patient

The three encounters above are patterns. The patient who stopped a medication because of a side effect his daughter correctly identified but no one had named as expected is in every BPH clinic. The patient who has built an elaborate system of compensations around a problem she calls “a veces, un poquito” is in every urology new-patient intake. The patient who arrives alone for a cancer treatment decision because the word cancer carries a specific death and he does not have the language to explain the difference is in every oncologic urology follow-up.

Three questions that find them:

“¿Ha habido algún cambio en cómo está tomando sus medicamentos desde la última vez que vino — alguno que dejó, alguno que redujo, o alguno que empezó a tomar de otra manera por algo que notó?”

The phrase “algo que notó” names what the patient who stopped a medication because of a side effect is waiting to report, without knowing if it is relevant. Aurelio had not brought up the tamsulosin discontinuation under the standard “¿cómo ha estado?” because he did not know whether a blood pressure reading his daughter took at home was something the nurse would want to know about. He was waiting for a question that signaled that changes in how he took medications were the topic. “Algo que notó” was that signal. The standard “¿está tomando sus medicamentos?” produces “sí” from the patient who stopped six weeks ago and has not yet reconnected the return of his urinary symptoms to the discontinuation.

“¿Hay algo que haya tenido que cambiar o dejar de hacer en su rutina del día — en el trabajo, en las salidas, en lo que come o bebe — por este problema?”

This question does not ask about symptoms. It asks about what the patient has changed. A patient who has built an entire system of compensations around a symptom she categorizes as ordinary, unremarkable aging answers this question with a list that reveals the actual severity. Rosa Elena’s ICIQ-SF score was 18/21. The standard intake questions would have produced a picture consistent with mild, intermittent incontinence — consistent with the PCP’s referral note. The functional question produced a forty-two-step route, eight minutes of early departure from every break, nine hours of daily fluid restriction, eight months of social isolation. Those are two different patients. The treatment plan for one is not the treatment plan for the other.

“¿Hay alguien en su familia que sepa el resultado de la biopsia — su esposa, sus hijos? ¿Ha tenido la oportunidad de hablar con ellos sobre lo que el médico le explicó?”

Matter-of-fact, not accusatory. A treatment decision visit where the patient arrives alone for a localized-prostate-cancer decision may be the first time anyone has noticed that no one in his household knows what this appointment is for. The patient who has not told his wife is not withholding out of fear alone — he is waiting until he has the language to explain something that does not sound like the death he watched. The nurse who offers him a specific sentence — not “tiene que decirle a su esposa” but the exact words that distinguish localized cancer from the cancer she knows — gives him a tool, not a mandate. The tool is what he was missing.

Graciela’s three questions in the small notebook changed the quality of a treatment decision that will live in their household for the next several years. Active surveillance requires quarterly PSA monitoring, annual biopsy, and sustained attention to a low-grade cancer over time. A partner who understands the monitoring logic — who knows what a rising PSA would mean and what stable means — is not incidental to that management. She is the person who notices if Ernesto stops going to appointments. The nurse who gave him the sentence that allowed the conversation also gave Graciela the role she was going to fill anyway — just with the information she needed.

The practice at ClinicaLingo covers these and similar conversations across thirty clinic and ED encounters. The post on medication reconciliation in Spanish covers the systematic approach to finding what the patient stopped and why, including the phrasing that distinguishes intentional discontinuation from missed doses from rationing for cost. The post on how to explain a diagnosis in Spanish covers the mechanism-first framing for conditions the patient cannot feel — including the distinction between a disease that announces itself with symptoms and one that does not. The post on discharge instructions in Spanish covers the teach-back method for confirming understanding before the patient leaves. The post on Spanish for urology nurses covers the inpatient and procedural urology conversations — the post-TURP patient who sees dark red drainage in the collection bag and believes something inside him has ruptured, the Foley catheter placed pre-operatively without explanation, and the prostate cancer biopsy result delivered as “encontraron cáncer de próstata” without Gleason grading, context, or a plan. The post on Spanish for nephrology clinic nurses covers the patient whose kidney function fell when he started feeling better, the patient who will not attend pre-dialysis education, and the patient who has not told her family she needs a living donor.

The 50-phrase PDF covers the intake, pain scale, allergy, and discharge vocabulary most nurses need most often on most shifts. The urology clinic posts cover the patterns that only appear at specific visit types — the alpha-blocker patient who stopped his medication because of a side effect no one told him to expect, the incontinence patient whose severity is invisible until you ask what she has changed, and the post-diagnosis patient who arrived alone to make a decision that belongs to two people.

These are not edge cases. They are the visit happening today, described by a nurse from Fresno last week and a nurse from Pomona the week before. The phrase that opens them is almost always simple. What it takes to use it well is knowing which question to reach for, and when.